在初次血管成形术期间，因严重呼吸困难停用坎格雷洛和替格瑞洛。 - Suppr

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

作者信息

Di Filippo Chiara, Caniato Flavia, Cappelli Francesco, Mattesini Alessio, Meucci Francesco, Sori Andrea, Stolcova Mira, Agostini Cecilia, Bernardo Pasquale, Di Mario Carlo

机构信息

Heart Lung and Vessels Department, Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.

DOI:10.2459/JCM.0000000000001042

PMID:33633048

Abstract

摘要

相似文献

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Circulation. 2019 Apr 2;139(14):1661-1670. doi: 10.1161/CIRCULATIONAHA.118.038317.

Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.

J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):825-828. doi: 10.2459/JCM.0000000000001006.

de Winter syndrome or inferior STEMI?

BMC Cardiovasc Disord. 2021 Dec 28;21(1):614. doi: 10.1186/s12872-021-02441-4.

Randomized Comparison of Oral P2Y-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 Trial.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):121-129. doi: 10.1016/j.jcin.2016.10.004.

Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):151-157. doi: 10.1093/ehjcvp/pvz002.

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.

Circulation. 2020 Aug 4;142(5):441-454. doi: 10.1161/CIRCULATIONAHA.120.046928. Epub 2020 Jun 27.

Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives.

J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):13-22. doi: 10.1177/1074248417715004. Epub 2017 Jun 15.

Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.

Resuscitation. 2018 Sep;130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30.

Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.

Circulation. 2017 Aug 8;136(6):602-604. doi: 10.1161/CIRCULATIONAHA.117.028745.

引用本文的文献

Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease.

Int J Mol Sci. 2024 May 28;25(11):5852. doi: 10.3390/ijms25115852.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

作者信息

Di Filippo Chiara, Caniato Flavia, Cappelli Francesco, Mattesini Alessio, Meucci Francesco, Sori Andrea, Stolcova Mira, Agostini Cecilia, Bernardo Pasquale, Di Mario Carlo

机构信息

Heart Lung and Vessels Department, Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.

DOI:10.2459/JCM.0000000000001042

PMID:33633048

Abstract

摘要

相似文献

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

J Cardiovasc Med (Hagerstown). 2021 Apr 1;22(4):317-319. doi: 10.2459/JCM.0000000000001042.

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Circulation. 2019 Apr 2;139(14):1661-1670. doi: 10.1161/CIRCULATIONAHA.118.038317.

Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.

J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):825-828. doi: 10.2459/JCM.0000000000001006.

de Winter syndrome or inferior STEMI?

BMC Cardiovasc Disord. 2021 Dec 28;21(1):614. doi: 10.1186/s12872-021-02441-4.

Randomized Comparison of Oral P2Y-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 Trial.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):121-129. doi: 10.1016/j.jcin.2016.10.004.

Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):151-157. doi: 10.1093/ehjcvp/pvz002.

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.

Circulation. 2020 Aug 4;142(5):441-454. doi: 10.1161/CIRCULATIONAHA.120.046928. Epub 2020 Jun 27.

Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives.

J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):13-22. doi: 10.1177/1074248417715004. Epub 2017 Jun 15.

Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.

Resuscitation. 2018 Sep;130:e1-e2. doi: 10.1016/j.resuscitation.2018.06.032. Epub 2018 Jun 30.

Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.

Circulation. 2017 Aug 8;136(6):602-604. doi: 10.1161/CIRCULATIONAHA.117.028745.

引用本文的文献

Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease.

Int J Mol Sci. 2024 May 28;25(11):5852. doi: 10.3390/ijms25115852.

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

作者信息

机构信息

出版信息

相似文献

引用本文的文献